Advancements in Dermatology: A Weekly Review
Dermatologia e Venerologia
Advances in Dermatology: New Therapies and Insights
This week's episode covers groundbreaking research in hidradenitis suppurativa, alopecia areata, atopic dermatitis, and cutaneous lupus erythematosus, featuring new biologic therapies and classification systems.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. Lutikizumab in Adults With Moderate to Severe Hidradenitis Suppurativa After Anti-TNF Therapy Failure: A Phase 2 Randomized Clinical Trial.
Authors: Kimball AB, Sawicki KT, Ackerman L, et al.
Journal: JAMA dermatology, 2026 May 1
PMID: 41848710
DOI: 10.1001/jamadermatol.2026.0155
2. Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.
Authors: Starace M, Rapparini L, Pampaloni F, et al.
Journal: American journal of clinical dermatology, 2026 May
PMID: 41855013
DOI: 10.1007/s40257-026-01022-5
3. Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study.
Authors: Kulthanan K, Bernstein JA, Rudenko M, et al.
Journal: American journal of clinical dermatology, 2026 May
PMID: 41843011
DOI: 10.1007/s40257-026-01015-4
4. Hidradenitis Suppurativa.
Authors: McCarthy S
Journal: Annual review of medicine, 2025 Jan
PMID: 39869430
DOI: 10.1146/annurev-med-051223-031234
5. Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.
Authors: Thaçi D, Puig L, Motegi SI, et al.
Journal: Acta dermato-venereologica, 2026 May 21
PMID: 42163822
DOI: 10.2340/actadv.v106.adv-2025-0160
6. Histopathologic classification and prognostic factors of melanoma: a 2021 update.
Authors: Bobos M
Journal: Italian journal of dermatology and venereology, 2021 Jun
PMID: 33982546
DOI: 10.23736/S2784-8671.21.06958-3
7. The growing epidemic of sexually transmitted infections in adolescents: a neglected population.
Authors: Shannon CL, Klausner JD
Journal: Current opinion in pediatrics, 2018 Feb
PMID: 29315111
DOI: 10.1097/MOP.0000000000000578
8. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
Authors: King B, Zhang X, Harcha WG, et al.
Journal: Lancet (London, England), 2023 May 6
PMID: 37062298
DOI: 10.1016/S0140-6736(23)00222-2
9. SERPINA12 in skin: molecular mechanisms and roles in adipocytes, psoriasis, and palmoplantar keratoderma.
Authors: Xiao Z, Wang F, Li R, et al.
Journal: Frontiers in immunology, 2026
PMID: 42125668
DOI: 10.3389/fimmu.2026.1812302
10. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
Authors: Niebel D, de Vos L, Fetter T, et al.
Journal: American journal of clinical dermatology, 2023 Jul
PMID: 37140884
DOI: 10.1007/s40257-023-00774-8
Authors: Kimball AB, Sawicki KT, Ackerman L, et al.
Journal: JAMA dermatology, 2026 May 1
PMID: 41848710
DOI: 10.1001/jamadermatol.2026.0155
2. Ritlecitinib for Severe Alopecia Areata: A 24-Week, Multicentre, Real-World Study.
Authors: Starace M, Rapparini L, Pampaloni F, et al.
Journal: American journal of clinical dermatology, 2026 May
PMID: 41855013
DOI: 10.1007/s40257-026-01022-5
3. Factors Associated with Symptomatic Dermographism: Findings from the UCARE PREVALENCE-D Study.
Authors: Kulthanan K, Bernstein JA, Rudenko M, et al.
Journal: American journal of clinical dermatology, 2026 May
PMID: 41843011
DOI: 10.1007/s40257-026-01015-4
4. Hidradenitis Suppurativa.
Authors: McCarthy S
Journal: Annual review of medicine, 2025 Jan
PMID: 39869430
DOI: 10.1146/annurev-med-051223-031234
5. Absolute Eczema Area and Severity Index Responses with Lebrikizumab in Patients with Moderate-to-severe Atopic Dermatitis: A Secondary Analysis of Two Phase 3 Trials.
Authors: Thaçi D, Puig L, Motegi SI, et al.
Journal: Acta dermato-venereologica, 2026 May 21
PMID: 42163822
DOI: 10.2340/actadv.v106.adv-2025-0160
6. Histopathologic classification and prognostic factors of melanoma: a 2021 update.
Authors: Bobos M
Journal: Italian journal of dermatology and venereology, 2021 Jun
PMID: 33982546
DOI: 10.23736/S2784-8671.21.06958-3
7. The growing epidemic of sexually transmitted infections in adolescents: a neglected population.
Authors: Shannon CL, Klausner JD
Journal: Current opinion in pediatrics, 2018 Feb
PMID: 29315111
DOI: 10.1097/MOP.0000000000000578
8. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.
Authors: King B, Zhang X, Harcha WG, et al.
Journal: Lancet (London, England), 2023 May 6
PMID: 37062298
DOI: 10.1016/S0140-6736(23)00222-2
9. SERPINA12 in skin: molecular mechanisms and roles in adipocytes, psoriasis, and palmoplantar keratoderma.
Authors: Xiao Z, Wang F, Li R, et al.
Journal: Frontiers in immunology, 2026
PMID: 42125668
DOI: 10.3389/fimmu.2026.1812302
10. Cutaneous Lupus Erythematosus: An Update on Pathogenesis and Future Therapeutic Directions.
Authors: Niebel D, de Vos L, Fetter T, et al.
Journal: American journal of clinical dermatology, 2023 Jul
PMID: 37140884
DOI: 10.1007/s40257-023-00774-8
